Antibody Drug Conjugates Against the Receptor for Advanced Glycation End Products (RAGE), a Novel Therapeutic Target in Endometrial Cancer
Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/s40425-019-0765-z
Full Text
Open PDFAbstract
Available in full text
Date
October 29, 2019
Authors
Publisher
BMJ